| Polypharmacy in type 2 diabetes mellitus: insights from an internal medicine department EC Dobrică, MA Găman, MA Cozma, OG Bratu, A Pantea Stoian, ... Medicina 55 (8), 436, 2019 | 107 | 2019 |
| Crosstalk of magnesium and serum lipids in dyslipidemia and associated disorders: a systematic review MA Găman, EC Dobrică, MA Cozma, NI Antonie, AMA Stănescu, ... Nutrients 13 (5), 1411, 2021 | 55 | 2021 |
| Dyslipidemia: a trigger for coronary heart disease in Romanian patients with diabetes MA Găman, MA Cozma, EC Dobrică, N Bacalbașa, OG Bratu, ... Metabolites 10 (5), 195, 2020 | 50 | 2020 |
| The involvement of oxidative stress in psoriasis: a systematic review EC Dobrică, MA Cozma, MA Găman, VM Voiculescu, AM Găman Antioxidants 11 (2), 282, 2022 | 48 | 2022 |
| Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity MA Gaman, EC Dobrica, EG Pascu, MA Cozma, ME Epingeac, ... Journal of Mind and Medical Sciences 6 (1), 157-161, 2019 | 43 | 2019 |
| Liquid biopsy and potential liquid biopsy-based biomarkers in Philadelphia-negative classical myeloproliferative neoplasms: a systematic review MA Găman, MA Cozma, EC Dobrică, SM Crețoiu, AM Găman, ... Life 11 (7), 677, 2021 | 28 | 2021 |
| Polypharmacy in the Management of Arterial Hypertension—Friend or Foe? CC Diaconu, MA Cozma, EC Dobrică, G Gheorghe, A Jichitu, VA Ionescu, ... Medicina 57 (12), 1288, 2021 | 19 | 2021 |
| Cret, oiu, SM; Găman, AM; Diaconu, CC Liquid biopsy and potential liquid biopsy-based biomarkers in philadelphia-negative classical myeloproliferative neoplasms: A systematic … MA Găman, MA Cozma, EC Dobrică Life 11 (677), 10.3390, 2021 | 16 | 2021 |
| A Glimpse at the Size of the Fetal Liver—Is It Connected with the Evolution of Gestational Diabetes? MA Cozma, MA Găman, EC Dobrică, SC Boroghină, MA Iancu, ... International Journal of Molecular Sciences 22 (15), 7866, 2021 | 8 | 2021 |
| Implications of type 2 diabetes mellitus in patients with acute cholangitis: a systematic review of current literature MA Cozma, EC Dobrică, P Shah, D Shellah, MA Găman, CC Diaconu Healthcare 10 (11), 2196, 2022 | 7 | 2022 |
| Bacalbas, a, N MA Găman, MA Cozma, EC Dobrică Bratu, OG, 0 | 6 | |
| Budd-Chiari syndrome in myeloproliferative neoplasms: A review of literature MA Găman, MA Cozma, MR Manan, BS Srichawla, A Dhali, S Ali, ... World Journal of Clinical Oncology 14 (3), 99, 2023 | 5 | 2023 |
| Laboratory findings in COVID-19-alterations of hematological, immunological, biochemical, hormonal and other lab panels: a narrative review Y Rasmi, LPJ Saavedra, MA Cozma, H El-Nashar, S Aly, N Fahmy, ... Journal of Mind and Medical Sciences 9 (1), 38-55, 2022 | 5 | 2022 |
| Macrovascular and microvascular complications in type 2 diabetes mellitus: did hypertension change the setting? E Dobrica, MA Gaman, MA Cozma, AM Gaman, CC Diaconu Journal of Hypertension 37, e140-e141, 2019 | 5 | 2019 |
| Polypharmacy in patients with chronic heart failure MA Gaman, EC Dobrica, MA Cozma, AM Gaman, CC Diaconu European Journal of Heart Failure 21, 421-422, 2019 | 2 | 2019 |
| A single centre experience in deep vein thrombosis: frequency of thrombophilia, chemotherapy agents and malignant conditions MA Găman, EC Dobrică, MA Cozma, AM Găman, CC Diaconu Clinical Lymphoma, Myeloma and Leukemia 18, S302, 2018 | 2 | 2018 |
| Toxicity of targeted anticancer treatments on the liver in myeloproliferative neoplasms S Purwar, A Fatima, H Bhattacharyya, LVS Kutikuppala, MA Cozma, ... World Journal of Hepatology 15 (9), 1021, 2023 | 1 | 2023 |
| Polypharmacy in the internal medicine department: the burden of arterial hypertension M Gaman, EC Dobrica, MA Cozma, AM Gaman, CC Diaconu Journal of Hypertension 37, e189, 2019 | 1 | 2019 |
| Bioactive Vitamins and Epigenetic Modifications in Diabetes: A Perspective EC Cozma, BS Srichawla, MA Cozma, H Kord Varkaneh, Y Chen, ... Current Diabetes Reviews 20 (1), 115-119, 2024 | | 2024 |
| Drug-induced liver injury: toxins and antidotes MA Cozma, M Mandea, CC Diaconu Antidotes to Toxins and Drugs, 195-220, 2024 | | 2024 |
MIHNEA-ALEXANDRU GĂMAN"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania & Department of HematologyVerified email at drd.umfcd.ro
